Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00742235 · ClinicalTrials.gov registry record · NA

hCAP18 Levels and Vitamin D Deficiency in Healthy Subjects

A NA study of Healthy Subjects and Vitamin D Deficiency, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
99
Enrollment target
1
Study location

NCT00742235 is a NA study of Healthy Subjects and Vitamin D Deficiency that has completed, run by Massachusetts General Hospital. The registered enrollment target is 99 participants, below the 127-participant average among 69 other Healthy Subjects trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00742235, a NA study of Healthy Subjects and Vitamin D Deficiency, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
99 participants
Enrollment target
1
Study location

Study Summary

Vitamin D deficiency (low levels of vitamin D in the blood) is a common problem. A recently discovered protein, called hCAP18, likely plays an important role in the immune system and may depend on adequate levels of vitamin D. It is not known what levels of vitamin D are needed to allow the body to make this protein. Nor is it known if giving vitamin D to people who are found to be deficient will help boost levels of hCAP18. This study aims to clarify the relationship between vitamin D levels and hCAP18.

Interventions

  • DRUG ergocalciferol

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 99 participants
Start Date 2007-07
Est. Completion 2012-01
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT00742235

The ClinicalTrials.gov registry entry for NCT00742235 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 127-participant average among 69 other Healthy Subjects trials with a reported enrollment target (22% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Healthy Subjects appearing as the primary indexed condition, and to 1 intervention - of which ergocalciferol is the first listed.

NCT00742235 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00742235 about?

NCT00742235 is a clinical study titled "hCAP18 Levels and Vitamin D Deficiency in Healthy Subjects". Vitamin D deficiency (low levels of vitamin D in the blood) is a common problem. A recently discovered protein, called hCAP18, likely plays an important role in the immune system and may depend on adequate levels of vitamin D. It is not known what levels of vitamin D are needed to allow the body to ...

What is the current status of trial NCT00742235?

This trial is currently completed. It is a NA study. The enrollment target is 99 participants. The study started on 2007-07. Estimated completion is 2012-01.

What conditions does trial NCT00742235 study?

This clinical trial studies the following conditions: Healthy Subjects, Vitamin D Deficiency.

What interventions are being tested in trial NCT00742235?

The interventions under investigation include: ergocalciferol (DRUG).

Who is sponsoring clinical trial NCT00742235?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00742235 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Subjects

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.